Defining the relationship between COPD and CVD: what are the implications for clinical practice?

AD Morgan, R Zakeri, JK Quint - Therapeutic advances in …, 2018 - journals.sagepub.com
Cardiovascular diseases (CVDs) are arguably the most important comorbidities in chronic
obstructive pulmonary disease (COPD). CVDs are common in people with COPD, and their …

Perioperative pulmonary atelectasis–part I: biology and mechanisms

C Zeng, D Lagier, JW Lee, MFV Melo - Anesthesiology, 2022 - pmc.ncbi.nlm.nih.gov
Pulmonary atelectasis is common in the perioperative period. Physiologically, it is produced
when collapsing forces derived from positive pleural pressure and surface tension overcome …

Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study

A Valipour, DJ Slebos, F Herth, K Darwiche… - American journal of …, 2016 - atsjournals.org
Rationale: Endobronchial valves (EBVs) have been successfully used in patients with
severe heterogeneous emphysema to improve lung physiology. Limited available data …

A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE)

GJ Criner, R Sue, S Wright, M Dransfield… - American journal of …, 2018 - atsjournals.org
Rationale: This is the first multicenter randomized controlled trial to evaluate the
effectiveness and safety of Zephyr Endobronchial Valve (EBV) in patients with little to no …

[HTML][HTML] A randomized study of endobronchial valves for advanced emphysema

FC Sciurba, A Ernst, FJF Herth, C Strange… - … England Journal of …, 2010 - Mass Medical Soc
Background Endobronchial valves that allow air to escape from a pulmonary lobe but not
enter it can induce a reduction in lobar volume that may thereby improve lung function and …

A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysema

National Emphysema Treatment Trial … - New England Journal …, 2003 - Mass Medical Soc
Background Lung-volume–reduction surgery has been proposed as a palliative treatment
for severe emphysema. Effects on mortality, the magnitude and durability of benefits, and …

Patients at high risk of death after lung-volume–reduction surgery

National Emphysema Treatment Trial … - New England Journal …, 2001 - Mass Medical Soc
Background Lung-volume–reduction surgery is a proposed treatment for emphysema, but
optimal selection criteria have not been defined. The National Emphysema Treatment Trial …

Amplification of inflammation in emphysema and its association with latent adenoviral infection

I Retamales, WM Elliott, B Meshi… - American journal of …, 2001 - atsjournals.org
This study examines the hypothesis that the cigarette smoke-induced inflammatory process
is amplified in severe emphysema and explores the association of this response with latent …

Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial …

KS Naunheim, DE Wood, Z Mohsenifar… - The Annals of thoracic …, 2006 - Elsevier
BACKGROUND: The National Emphysema Treatment Trial defined subgroups of patients
with severe emphysema in whom lung-volume-reduction surgery (LVRS) improved survival …

Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial

PL Shah, Z Zoumot, S Singh, SR Bicknell… - The Lancet …, 2013 - thelancet.com
Background Few treatment options exist for patients with severe emphysema. We assessed
the clinical benefits and safety of lung volume reduction coils (LVRCs) for the treatment of …